Page last updated: 2024-12-04

alpha-cyano-4-hydroxycinnamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2102
MeSH IDM0050204

Synonyms (34)

Synonym
nsc-173138
DIVK1C_000219
KBIO1_000219
SPECTRUM_001499 ,
KBIO2_001979
KBIO3_001480
KBIO2_007115
KBIOGR_000707
KBIOSS_001979
KBIO2_004547
SPECTRUM4_000334
SPECTRUM2_001947
SPECTRUM3_000730
NINDS_000219
SPBIO_002013
C1768
alpha-cyano-4-hydroxycinnamate
2-cyano-4-hydroxycinnamate
4-hydroxy-alpha-cyanocinnamate
einecs 248-879-1
nl5eem9e2g ,
unii-nl5eem9e2g
nsc 173138
FT-0612097
FT-0622132
alpha-cyano4-hydroxycinnamic acid
AFVLVVWMAFSXCK-UHFFFAOYSA-N
2-cyano-3-(4-hydroxyphenyl) acrylic acid
2-cyano-3-(4-hydroxy-phenyl)-acrylic acid
4-hydroxy-alpha-cyanocinnamic acid
AKOS028110673
HMS3867D03
HMS3741O15
gtpl11300
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (333)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (10.21)18.7374
1990's47 (14.11)18.2507
2000's120 (36.04)29.6817
2010's119 (35.74)24.3611
2020's13 (3.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.15 (24.57)
Research Supply Index5.82 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index19.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.30%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other334 (99.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]